Skip to main content

Table 1 Association between KCF-S “RING C1x-C1x-C1y(C1z)-C1y(C2x)-C1y-C1x-C1x-C1z(C5a+O7a)-C1z(C1a)” and KEGG pathway hsa04080 Neuroactive “ligand-receptor interaction”. See also Fig. 4

From: Network-based characterization of drug-protein interaction signatures with a space-efficient approach

KCF-S RING C1x-C1x-C1y(C1z)-C1y(C2x)-C1y-C1x-
Pathway hsa04080 Neuroactive ligand-receptor interaction
Drug D00952 Megestrol acetate (antineoplastic)
  D01299 Chlormadinone acetate (progestin)
  D01368 Cyproterone acetate (anti-androgen)
Protein hsa:10800 cysteinyl leukotriene receptor 1
  hsa:1128-hsa:1133 muscarinic acetylcholine receptor M1 - M5
  hsa:1134 nicotinic acetylcholine receptor alpha-1
  hsa:1268 cannabinoid receptor 1
  hsa:134,hsa:135,hsa:140 adenosine A1 receptor A1, A2a, A3
  hsa:146,hsa:150,hsa:151 adrenergic receptor alpha-1D,2A,2B
  hsa:1511 cathepsin G
  hsa:152 adrenergic receptor alpha-2C
  hsa:153-hsa:155 adrenergic receptor beta-1,2,3
  hsa:1812-hsa:1816 dopamine receptor D1-D5
  hsa:185-hsa:186 angiotensin II receptor type 1,2
  hsa:1909-hsa:1910 endothelin receptor type A, B
  hsa:2908 glucocorticoid receptor
  hsa:3269,hsa:3274 histamine receptor H1,H2
  hsa:3356,hsa:3357,hsa:3358 5-hydroxytryptamine receptor 2
  hsa:3362 5-hydroxytryptamine receptor 6
  hsa:4159-hsa:4161 melanocortin receptor 3,4,5
  hsa:4886,hsa:4887 neuropeptide Y receptor type 1/4/6,2
  hsa:4985 delta-type opioid receptor
  hsa:4986 kappa-type opioid receptor
  hsa:4988 mu-type opioid receptor
  hsa:552 arginine vasopressin receptor 1A
  hsa:5724 platelet-activating factor receptor
  hsa:624 bradykinin receptor B2
  hsa:6865,hsa:6869 tachykinin receptor 1,2
  hsa:7068 thyroid hormone receptor beta
  hsa:7253 thyroid stimulating hormone receptor
  hsa:7433 vasoactive intestinal peptide receptor 1
  hsa:886 cholecystokinin A receptor